
How Innovation is at the Heart of Independent PBM LucyRx
In a conversation with David Blair, CEO of LucyRx, he discussed his company’s unique business model and how it is giving back to patients, providers, and plan sponsors alike.
The pharmacy industry has long been suffering from declining reimbursements and an inability to keep a sustainable business model amidst pressures from pharmacy benefit managers (PBMs) and the drug market as a whole. With many experts calling on federal legislation to correct the issues in pharmacy, others are looking toward innovation to make the change themselves.
“
Blair sat down with Drug Topics to discuss the work of LucyRx and how its business model differs from that of other market-leading PBMs like CVS Caremark, Express Scripts, Optum Rx, and others. With the robust amount of data, analytics, and expertise LucyRx has at its disposal, they are aiming to reduce costs and improve health outcomes on a national level.
Find out about the industry-changing momentum behind LucyRx and how companies like these are making a real difference within health care, as pharmacists and other pharmacy employees constantly face industry pressures.
Also, stay tuned for more from our conversation with Blair as he looks toward the future of pharmacy benefits and how his company is facilitating the evolution of pharmacy delivery in the US.
READ MORE:
Pharmacy practice is always changing. Stay ahead of the curve: Sign up for our
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.